Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
OMI 
Owens & Minor Inc (OMI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/13/2025: OMI (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
6 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $5.7
1 Year Target Price $5.7
| 2 | Strong Buy |
| 0 | Buy |
| 2 | Hold |
| 2 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -50.35% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/13/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 216.57M USD | Price to earnings Ratio - | 1Y Target Price 5.7 |
Price to earnings Ratio - | 1Y Target Price 5.7 | ||
Volume (30-day avg) 6 | Beta 1.34 | 52 Weeks Range 2.79 - 15.54 | Updated Date 11/14/2025 |
52 Weeks Range 2.79 - 15.54 | Updated Date 11/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -5.69 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-10-30 | When - | Estimate 0.236 | Actual 0.25 |
Profitability
Profit Margin -12.45% | Operating Margin (TTM) 8.08% |
Management Effectiveness
Return on Assets (TTM) 3.75% | Return on Equity (TTM) -196.39% |
Valuation
Trailing PE - | Forward PE 3.55 | Enterprise Value 2390401520 | Price to Sales(TTM) 0.02 |
Enterprise Value 2390401520 | Price to Sales(TTM) 0.02 | ||
Enterprise Value to Revenue 0.22 | Enterprise Value to EBITDA 98.73 | Shares Outstanding 77346594 | Shares Floating 61156405 |
Shares Outstanding 77346594 | Shares Floating 61156405 | ||
Percent Insiders 3.43 | Percent Institutions 83.1 |
Upturn AI SWOT
Owens & Minor Inc
Company Overview
History and Background
Owens & Minor, Inc. was founded in 1882 in Richmond, Virginia. Originally a wholesale drug company, it evolved into a leading global healthcare solutions company focused on supply chain services and product manufacturing. Over the years, it expanded its product portfolio and geographic reach through organic growth and strategic acquisitions.
Core Business Areas
- Products & Healthcare Services: Focuses on providing medical and surgical supplies, distribution, and supply chain solutions to healthcare providers, manufacturers, and patients. Includes national brands, proprietary brands, and extended value services.
Leadership and Structure
The company is led by a Chief Executive Officer (CEO) and a senior management team responsible for overseeing various business functions. The organizational structure includes departments for sales, marketing, operations, finance, and human resources.
Top Products and Market Share
Key Offerings
- Medical and Surgical Supplies: Includes a broad range of products such as gloves, gowns, syringes, wound care products, and surgical instruments. Market share varies by product category, competing with Cardinal Health and Medline Industries. Specific revenue data is not publicly broken out by product line. Competitors: Cardinal Health (CAH), Medline Industries.
- Distribution Services: Distribution services for medical and surgical supplies, providing logistical support to hospitals and healthcare providers. Market share is competitive, depending on the region, and the size of hospital networks. Competitors: Cardinal Health (CAH), McKesson (MCK).
Market Dynamics
Industry Overview
The healthcare supply chain industry is driven by factors such as aging populations, increasing healthcare spending, and technological advancements in medical treatments. It is a competitive market with a few major players and many smaller regional distributors.
Positioning
Owens & Minor positions itself as a comprehensive solutions provider, offering a broad range of products and services. Its competitive advantage lies in its established relationships with healthcare providers and its supply chain expertise.
Total Addressable Market (TAM)
The global healthcare supply chain management market size was valued at USD 2.11 billion in 2023 and is projected to grow from USD 2.25 billion in 2024 to USD 3.97 billion by 2032. OMI is positioned as a key player in this market, especially in the US, yet with substantial competition
Upturn SWOT Analysis
Strengths
- Established relationships with healthcare providers
- Comprehensive product and service offerings
- Extensive distribution network
- Supply chain expertise
- Proprietary brand portfolio
Weaknesses
- High debt levels
- Dependence on key customers
- Exposure to regulatory changes
- Intense competition
Opportunities
- Expanding into new geographic markets
- Increasing adoption of supply chain technology
- Acquiring smaller competitors
- Offering value-added services such as data analytics and consulting
Threats
- Price pressures from healthcare providers
- Disruptions to the supply chain
- Changes in government regulations
- Economic downturns
Competitors and Market Share
Key Competitors
- CAH
- MCK
- BAX
- SYK
Competitive Landscape
Owens & Minor competes with other major healthcare distributors, each with its strengths and weaknesses. Owens & Minor is focusing on its services offering as its differentiators.
Major Acquisitions
Aprio Healthcare
- Year: 2019
- Acquisition Price (USD millions): 160
- Strategic Rationale: To expand its offerings in the acute care market and supply chain solutions.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been a mix of organic expansion and acquisitions.
Future Projections: Future growth will depend on successful execution of strategic initiatives and external factors.
Recent Initiatives: Recent initiatives include supply chain optimization, expansion of product offerings, and technological upgrades.
Summary
Owens & Minor is a established player in the healthcare supply chain. The company is focusing on its products and services offering. Weaknesses include it's market share compared to its competitors. They need to be aware of changes in healthcare policies that may cause headwinds.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Industry Reports
- Analyst Estimates
- Company Website
Disclaimers:
The data and analysis provided are for informational purposes only and should not be considered financial advice. Market conditions and company performance can change rapidly. Consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Owens & Minor Inc
Exchange NYSE | Headquaters Glen Allen, VA, United States | ||
IPO Launch date 1988-12-16 | President, CEO & Director Mr. Edward A. Pesicka | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 23200 | Website https://www.owens-minor.com |
Full time employees 23200 | Website https://www.owens-minor.com | ||
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. The company operates in two segments, Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment also supplies a range of other home medical equipment; and patient care products, including ostomy, wound care, urology, and incontinence and other products and services. The company serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is based in Glen Allen, Virginia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.